Course Type: On-Demand Webcourse 
Number of Credits: 1

Get Started

The CME program, Nonmelanoma Skin Cancers: Current and Emerging Checkpoint Inhibitors for Treating Advanced Basal Cell and Squamous Cell Carcinomas, will provide oncologists with current guideline-based diagnostic, staging, and treatment strategies for patients with advanced BCC and CSCC as well as how newly approved and agents in development fit into treatment strategies.

Get Started


Roman Groisberg, MD
Assistant Professor, Medical Oncology
Department of Melanoma and Sarcoma
Rutgers Cancer Institute of New Jersey
New Brunswick, NJ

Max Lenowitz, CRNP
Jefferson Medical Oncology
Philadelphia, PA

Melissa Wilson, MD, PhD
Medical Oncology Fellowship Program Director/Melanoma Program Director
St. Luke’s Cancer Center – St. Luke’s University Health Network
Easton, PA



Jointly provided by the Potomac Center for Medical Education and Rockpointe

Nursing credit provided by Amedco


This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme.